NCT07179302

Brief Summary

The aim of this study is to evaluate the combined utility of the left atrial coupling index (LACI) and left ventricular speckle tracking echocardiography (LVSTE) in improving risk stratification and outcome prediction for patients undergoing Transcatheter Aortic Valve Implantation (TAVI). This study seeks to identify novel prognostic markers that enhance the prediction of mortality, heart failure, and functional recovery, ultimately enabling more personalized clinical decision-making and optimized patient outcomes by integrating the advanced echocardiographic parameters into pre-procedural assessments,.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

9 months

First QC Date

September 10, 2025

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Repeated hospitalization in one year

    number of patients need rehospitalization

    one year

  • Need for permanent pacemaker

    number of patients need for permanent pacemaker

    6 months

  • Myocardial infarction within one year

    incidence of MI in patients

    one year

  • Stroke in one year

    incidence of stroke in patients

    one year

Study Arms (1)

TAVI group

Patients undergoing Transcatheter Aortic Valve Implantation.

Procedure: Transcatheter Aortic Valve Implantation (TAVI)

Interventions

evaluate the role of the left atrial coupling index (LACI) and left ventricular speckle tracking echocardiography (LVSTE) in enhancing outcome prediction in patients undergoing TAVI.

Also known as: TAVI
TAVI group

Eligibility Criteria

Age50 Years - 102 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with severe aortic stenosis and scheduled for TAVI will be recruited from Madina Cardiac Center over a period of 12 months Data Collection * Baseline Clinical Data: Demographic information, comorbidities, and clinical risk scores * Echocardiographic Assessment: Pre procedural transthoracic echocardiography (TTE) will be performed to measure: Left Atrial Coupling Index (LACI): Left Ventricular Speckle Tracking Echocardiography (LVSTE): Global longitudinal strain (GLS) will be measured to quantify myocardial deformation. All echocardiographic measurements will be performed by experienced operators blinded to clinical outcomes.

You may qualify if:

  • Patients diagnosed with severe aortic stenosis and scheduled for TAVI.

You may not qualify if:

  • Patients with significant mitral or tricuspid valve disease requiring intervention.
  • History of atrial fibrillation or other arrhythmias that preclude accurate LACI measurement.
  • Poor echocardiographic window preventing reliable imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tanta University

Tanta, Gharbia Governorate, 31527, Egypt

Location

Medina Medical Center

Madinah, Saudi Arabia

Location

Related Publications (2)

  • Wu HW, Fortuni F, Butcher SC, van der Kley F, de Weger A, Delgado V, Jukema JW, Bax JJ, Ajmone Marsan N. Prognostic value of left ventricular myocardial work indices in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J Cardiovasc Imaging. 2023 Nov 23;24(12):1682-1689. doi: 10.1093/ehjci/jead157.

    PMID: 37409583BACKGROUND
  • Takeuchi K, Yamauchi Y, Shiraki H, Sumimoto K, Shono A, Suzuki M, Yamashita K, Toba T, Kawamori H, Otake H, Hirata KI, Tanaka H. Association of acute improvement in left ventricular longitudinal function after transcatheter aortic valve implantation with outcomes for severe aortic stenosis and preserved ejection fraction. J Cardiol. 2023 Oct;82(4):234-239. doi: 10.1016/j.jjcc.2023.04.008. Epub 2023 Apr 19.

    PMID: 37085029BACKGROUND

MeSH Terms

Conditions

Aortic Valve Stenosis

Interventions

Transcatheter Aortic Valve Replacement

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Intervention Hierarchy (Ancestors)

Heart Valve Prosthesis ImplantationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationThoracic Surgical Procedures

Study Officials

  • Eman Elshaikh, Ass Prof.

    Madina Cardiac Center, KSA

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 10, 2025

First Posted

September 17, 2025

Study Start

February 1, 2025

Primary Completion

October 30, 2025

Study Completion

November 1, 2025

Last Updated

December 3, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations